Clinical Trial Update: Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update studying molecular and genetic abnormalities in patients with myeloid neoplasms, including Acute myeloid leukemia, Myelodysplastic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: Acute Myeloid Leukemia, Myeloproliferative Neoplasms | Phase 2 | Status: COMPLETED